Evaluate Drug Success and Manage Portfolio Risk: Pharmapremia is Here.
A robust, stand-alone, web-based tool, Pharmapremia gives you the ability to accurately benchmark internal and external R&D candidates’ chances of approval and potential development timelines — benchmarks you can use to make informed decisions regarding pipeline prioritization, partnerships and acquisitions. Pharmapremia covers over 7,000 programs, including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.
How Pharmapremia can help
Pharmapremia gives you the power to look at product success factors across the variables that matter to you and your business. Using a robust dataset that includes detailed information from the entire drug-development industry, from big pharma to private biotech, oncology to orphan diseases, Pharmapremia gives you an exclusive window into drug development pipelines and paints a fuller, clearer picture of what drug success really looks like in our industry.
Effectively manage your portfolio risk by accessing comprehensive data sets including Probability of Overall Success (POS), Likelihood of Approval (LOA) and Phase and Overall Duration.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: